Development of an injectable formulation of albendazole and in vivo evaluation of its efficacy against Echinococcus multilocularis metacestode

This publication has 18 references indexed in Scilit:

• In vitro quantitative assessment of Echinococcus multilocularis metacestode viability after in vivo and in vitro maintenance
  International Journal for Parasitology, 1995
• Experience with doxorubicin-bound polyisohexylcyanoacrylate nanoparticles on murine alveolar echinococcosis of the liver
  International Journal for Parasitology, 1993
• Effect of surfactants on Albendazole absorption
  Journal of Pharmaceutical and Biomedical Analysis, 1991
• Dexamethasone increases plasma levels of albendazole
  Journal of Neurology, 1990
• Albendazole kinetics in patients with echinococcosis: Delayed absorption and impaired elimination in cholestasis
  European Journal of Clinical Pharmacology, 1990
• Increased systemic availability of albendazole when taken with a fatty meal
  European Journal of Clinical Pharmacology, 1988
• A comparison of the effects of albendazole, its sulphone metabolite, and mebendazole on the viability of protoscoleces of Echinococcus granulosus in an in vitro culture system
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1987
• Effect of albendazole sulphoxide on viability of hydatid protoscoleces in vitro
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1986
• Experimental alveolar echinococcosis. Suitability of a murine model of intrahepatic infection byEchinococcus multilocularis for immunological studies
  Cellular and Molecular Life Sciences, 1984
• Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
  Journal of Immunological Methods, 1983